Abbott Discontinued Operations vs Gross Profit Analysis
ABT Stock | USD 104.01 0.76 0.73% |
Abbott Laboratories financial indicator trend analysis is way more than just evaluating Abbott Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abbott Laboratories is a good investment. Please check the relationship between Abbott Laboratories Discontinued Operations and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Discontinued Operations vs Gross Profit
Discontinued Operations vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abbott Laboratories Discontinued Operations account and Gross Profit. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Abbott Laboratories' Discontinued Operations and Gross Profit is -0.38. Overlapping area represents the amount of variation of Discontinued Operations that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Abbott Laboratories, assuming nothing else is changed. The correlation between historical values of Abbott Laboratories' Discontinued Operations and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Discontinued Operations of Abbott Laboratories are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Discontinued Operations i.e., Abbott Laboratories' Discontinued Operations and Gross Profit go up and down completely randomly.
Correlation Coefficient | -0.38 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Discontinued Operations
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Abbott Laboratories minus its cost of goods sold. It is profit before Abbott Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Abbott Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abbott Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.At this time, Abbott Laboratories' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 19.89 in 2024, whereas Tax Provision is likely to drop slightly above 949.8 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 24.5B | 24.5B | 22.1B | 12.5B | Total Revenue | 43.1B | 43.7B | 40.1B | 22.2B |
Abbott Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
Abbott Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Abbott Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 67.9B | 72.5B | 75.2B | 74.4B | 73.2B | 36.9B | |
Short Long Term Debt Total | 18.9B | 19.6B | 19.0B | 17.7B | 15.9B | 9.8B | |
Other Current Liab | 6.1B | 7.7B | 7.9B | 8.6B | 7.7B | 8.1B | |
Total Current Liabilities | 10.9B | 11.9B | 13.1B | 15.5B | 13.8B | 8.3B | |
Total Stockholder Equity | 31.1B | 32.8B | 35.8B | 36.7B | 38.6B | 40.5B | |
Property Plant And Equipment Net | 8.0B | 9.0B | 9.0B | 9.2B | 11.3B | 6.2B | |
Net Debt | 15.0B | 12.8B | 9.2B | 7.8B | 9.0B | 6.1B | |
Retained Earnings | 25.8B | 27.6B | 31.5B | 35.3B | 37.6B | 39.4B | |
Cash | 3.9B | 6.8B | 9.8B | 9.9B | 6.9B | 3.7B | |
Non Current Assets Total | 52.2B | 52.1B | 51.0B | 49.2B | 50.5B | 53.1B | |
Non Currrent Assets Other | 52.2B | 3.7B | 5.2B | 6.0B | 6.0B | 3.0B | |
Cash And Short Term Investments | 4.1B | 7.1B | 10.2B | 10.2B | 7.3B | 4.3B | |
Net Receivables | 5.4B | 6.4B | 6.5B | 8.9B | 6.6B | 3.9B | |
Common Stock Shares Outstanding | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B | 1.3B | |
Liabilities And Stockholders Equity | 67.9B | 72.5B | 75.2B | 74.4B | 73.2B | 36.9B | |
Non Current Liabilities Total | 25.7B | 27.6B | 26.1B | 22.0B | 20.5B | 11.7B | |
Inventory | 4.3B | 5.0B | 5.2B | 6.2B | 6.6B | 6.9B | |
Other Current Assets | 1.8B | 1.9B | 2.3B | 2.7B | 2.3B | 2.2B | |
Other Stockholder Equity | (10.1B) | (10.0B) | (11.8B) | (15.2B) | (16.0B) | (16.8B) | |
Total Liab | 36.6B | 39.5B | 39.2B | 37.5B | 34.4B | 20.0B | |
Property Plant And Equipment Gross | 8.0B | 9.0B | 19.4B | 20.2B | 21.9B | 23.0B | |
Total Current Assets | 15.7B | 20.4B | 24.2B | 25.2B | 22.7B | 13.3B | |
Accumulated Other Comprehensive Income | (8.5B) | (8.9B) | (8.4B) | (8.1B) | (7.8B) | (7.4B) | |
Short Term Debt | 207M | 1.5B | 220M | 754M | 2.3B | 2.0B | |
Accounts Payable | 3.3B | 3.9B | 4.4B | 4.6B | 4.3B | 4.5B | |
Common Stock Total Equity | 23.9B | 24.1B | 24.5B | 24.7B | 28.4B | 29.8B | |
Short Term Investments | 280M | 310M | 450M | 288M | 383M | 757.2M | |
Common Stock | 23.9B | 24.1B | 24.5B | 24.7B | 24.9B | 23.6B | |
Intangible Assets | 17.0B | 14.8B | 12.7B | 10.5B | 8.8B | 9.1B | |
Other Liab | 8.3B | 8.2B | 7.8B | 6.6B | 7.6B | 5.7B | |
Other Assets | 2.4B | 2.8B | 4.1B | 4.9B | 5.7B | 5.9B | |
Long Term Debt | 16.7B | 18.5B | 17.3B | 14.5B | 13.6B | 12.0B | |
Treasury Stock | (10.0B) | (10.1B) | (10.0B) | (11.8B) | (10.6B) | (10.1B) | |
Property Plant Equipment | 8.0B | 9.0B | 9.0B | 9.2B | 10.5B | 7.7B | |
Good Will | 23.2B | 23.7B | 23.2B | 22.8B | 23.7B | 15.5B | |
Net Tangible Assets | (70M) | 3.4B | (2.2B) | 11.0B | 9.9B | 10.4B | |
Noncontrolling Interest In Consolidated Entity | 198M | 213M | 219M | 222M | 251.9M | 163.8M | |
Retained Earnings Total Equity | 25.8B | 27.6B | 31.5B | 35.3B | 40.5B | 27.2B | |
Long Term Debt Total | 16.7B | 18.5B | 17.3B | 14.5B | 16.7B | 15.8B |
Pair Trading with Abbott Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving together with Abbott Stock
0.72 | DH | Definitive Healthcare | PairCorr |
0.75 | DOCS | Doximity Earnings Call This Week | PairCorr |
0.77 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
Moving against Abbott Stock
0.72 | GCTK | GlucoTrack | PairCorr |
0.58 | RDNT | RadNet Inc | PairCorr |
0.57 | WGS | GeneDx Holdings Corp | PairCorr |
0.56 | SLP | Simulations Plus Financial Report 4th of July 2024 | PairCorr |
0.41 | CMAXW | CareMax | PairCorr |
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.181 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.